Author
Listed:
- Helen R Fryer
- Tanya Golubchik
- Matthew Hall
- Christophe Fraser
- Robert Hinch
- Luca Ferretti
- Laura Thomson
- Anel Nurtay
- Lorenzo Pellis
- Thomas House
- George MacIntyre-Cockett
- Amy Trebes
- David Buck
- Paolo Piazza
- Angie Green
- Lorne J Lonie
- Darren Smith
- Matthew Bashton
- Matthew Crown
- Andrew Nelson
- Clare M McCann
- Mohammed Adnan Tariq
- Claire J Elstob
- Rui Nunes Dos Santos
- Zack Richards
- Xin Xhang
- Joseph Hawley
- Mark R Lee
- Priscilla Carrillo-Barragan
- Isobel Chapman
- Sarah Harthern-Flint
- The COVID-19 Genomics UK (COG-UK) consortium
- David Bonsall
- Katrina A Lythgoe
Abstract
In this study, we evaluated the impact of viral variant, in addition to other variables, on within-host viral burden, by analysing cycle threshold (Ct) values derived from nose and throat swabs, collected as part of the UK COVID-19 Infection Survey. Because viral burden distributions determined from community survey data can be biased due to the impact of variant epidemiology on the time-since-infection of samples, we developed a method to explicitly adjust observed Ct value distributions to account for the expected bias. By analysing the adjusted Ct values using partial least squares regression, we found that among unvaccinated individuals with no known prior exposure, viral burden was 44% lower among Alpha variant infections, compared to those with the predecessor strain, B.1.177. Vaccination reduced viral burden by 67%, and among vaccinated individuals, viral burden was 286% higher among Delta variant, compared to Alpha variant, infections. In addition, viral burden increased by 17% for every 10-year age increment of the infected individual. In summary, within-host viral burden increases with age, is reduced by vaccination, and is influenced by the interplay of vaccination status and viral variant.Author summary: The SARS-CoV-2 epidemic in the United Kingdom (UK) has been characterized by the successive transmission of distinct viral variants. Viral variation can impact viral properties, including infectiousness and pathogenicity. These properties may be linked to the amount of virus present in an infected individual. In this study, we examined the association between intra-patient viral burden and a range of factors, including viral variant, using a large, population-representative SARS-CoV-2 survey conducted in the UK. As part of our investigation, we developed a novel method to account for bias in sampled viral burden resulting from the study’s sampling methodology. Our findings indicate that viral burden within the host increases with age, is reduced by vaccination, and is influenced by the interplay between vaccination status and viral variant.
Suggested Citation
Helen R Fryer & Tanya Golubchik & Matthew Hall & Christophe Fraser & Robert Hinch & Luca Ferretti & Laura Thomson & Anel Nurtay & Lorenzo Pellis & Thomas House & George MacIntyre-Cockett & Amy Trebes , 2023.
"Viral burden is associated with age, vaccination, and viral variant in a population-representative study of SARS-CoV-2 that accounts for time-since-infection-related sampling bias,"
PLOS Pathogens, Public Library of Science, vol. 19(8), pages 1-24, August.
Handle:
RePEc:plo:ppat00:1011461
DOI: 10.1371/journal.ppat.1011461
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:ppat00:1011461. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plospathogens (email available below). General contact details of provider: https://journals.plos.org/plospathogens .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.